Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.3 to v3.6.4, signaling a minor update to the record's metadata; no changes to the study content are indicated.
    Difference
    0.0%
    Check dated 2026-07-28T05:17:49.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.6.2 to v3.6.3, indicating a minor site update. No core content or study data on the page is affected by this change.
    Difference
    0.0%
    Check dated 2026-07-06T16:37:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the page, signaling a version update of the page rendering. This appears to be a backend/content-management-system update rather than a modification to the study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-29T08:41:50.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now adds sections that guide users (How to Read a Study Record, Common Questions, How to Join a Study) and explicitly states that recruitment has ended; it also updates the Revision line from v3.5.5 to v3.6.0 and adjusts the Intervention/Treatment heading formatting.
    Difference
    0.4%
    Check dated 2026-06-15T08:22:39.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor platform or content-management update. The underlying study information and visible content remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-08T04:23:04.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    - The page's revision label has been updated from v3.5.3 to v3.5.4. - This signals a minor site version update that affects rendering but not the study data.
    Difference
    0.0%
    Check dated 2026-05-17T10:01:16.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.